✦ LIBER ✦

Current attitudes of head and neck oncologists in the United Kingdom to induction chemotherapy for locally advanced head and neck cancer: A survey of centres participating in a national randomised controlled trial

✍ Scribed by Gujral, D.M.; Piercy, D.; Morden, J.P.; Emson, M.; Hall, E.; Miah, A.B.; Bhide, S.A.; Newbold, K.L.; Harrington, K.J.; Nutting, C.M.

Book ID: 125445603
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 736 KB
Volume: 50
Category: Article
ISSN: 1368-8375
DOI: 10.1016/j.oraloncology.2013.10.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S7.1 Is there a role for induction chemo

S7.1 Is there a role for induction chemotherapy in the treatment of locally advanced head and neck cancer?

✍ A.A. Forastiere 📂 Article 📅 2005 🏛 Elsevier Science ⚖ 122 KB

Improved Outcomes With Carboplatin-Pacli

Improved Outcomes With Carboplatin-Paclitaxel Compared to Docetaxel-Cisplatin-5-Fluorouracil Induction Chemotherapy in Locally-Advanced Squamous Cell Cancer of the Head and Neck

✍ Herman, L.; Garnett, A.; Spiotto, M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

A Matched Analysis Evaluating the Role o

A Matched Analysis Evaluating the Role of Triple-Agent Induction Chemotherapy in the Context of Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Locally Advanced Head-and-Neck Cancer

✍ Wobb, J.L.; Warner, J.; Huang, J.; Baschnagel, A.; Stromberg, J.; Jaiyesimi, I.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

-Tubulin-II Expression Strongly Predicts

-Tubulin-II Expression Strongly Predicts Outcome in Patients Receiving Induction Chemotherapy for Locally Advanced Squamous Carcinoma of the Head and Neck: A Companion Analysis of the TAX 324 Trial

✍ Cullen, K. J.; Schumaker, L.; Nikitakis, N.; Goloubeva, O.; Tan, M.; Sarlis, N. 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 160 KB

cis-diamminedichloroplatinum (II) and bl

cis-diamminedichloroplatinum (II) and bleomycin induction chemotherapy as an adjuvant to conventional treatment modalities in advanced head and neck cancer preliminary report of the results of a non-randomized trial and control series

✍ Alptekin Ucmakli; Waun Ki Hong; Stanley M. Shapshay; M. Stuart Strong; Charles W 📂 Article 📅 1978 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Dysphagia and Dose Reduction to Dysphagi

Dysphagia and Dose Reduction to Dysphagia/Aspiration-Related Structures (DARS) in Patients Receiving Induction Chemotherapy (IC) Followed by Concurrent Chemoradiation Therapy (CCRT) for Locally-Advanced Squamous Cell Carcinoma of the Head and Neck (LASCCHN)

✍ Kann, B.H.; Carpenter, T.J.; Todorov, B.; Golchin, A.; Bakst, R.; Misiukiewicz, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 61 KB